Alejandro
Martín García Sancho
Profesor Asociado CC. Salud
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublications in collaboration with researchers from Instituto de Investigación Biomédica de Salamanca (8)
2024
2023
2022
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 11, pp. 1196-1205
-
TCL-318 Evaluation of the Antitumor Activity of Amiloride in Peripheral T-Cell Lymphomas Using In-Vitro Models
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S399
2020
-
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier
Blood, Vol. 135, Núm. 13, pp. 996-1007
2018
-
A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease
Blood Advances, Vol. 2, Núm. 21, pp. 2959-2963
2016
-
Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma
British Journal of Clinical Pharmacology, Vol. 82, Núm. 6, pp. 1517-1527